Edwards LifesciencesEW +3.12%97 OCF Margin % is 2.66% as of Mar. 2026, which is 90% below its 10-year median of 25.59. GuruFocus rates EW with a GF Score™ of 97/100 and a GF Value™ of $93.14 (Fairly Valued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Edwards Lifesciences ranks better than 82.94% on this metric.
The historical rank and industry rank for Edwards Lifesciences's OCF Margin % or its related term are showing as below:
EW'
s OCF Margin % Range Over the Past 10 Years
Min: 9.97 Med: 25.59 Max: 33.1
Current: 21.55
During the past 13 years, the highest OCF Margin % of Edwards Lifesciences was 33.10%. The lowest was 9.97%. And the median was 25.59%.
EW's OCF Margin % is ranked better than 82.94% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs EW: 21.55
Edwards Lifesciences OCF Margin % Related Terms
Edwards Lifesciences OCF Margin % Historical Data
* Premium members only.
The historical data trend for Edwards Lifesciences's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Edwards Lifesciences's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edwards Lifesciences OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Edwards Lifesciences's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edwards Lifesciences (EW) has a OCF Margin % of 2.66% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Edwards Lifesciences and its competitors. This is 90% below median its historical median of 25.59. Over the past decade, Edwards Lifesciences' OCF Margin % has ranged from 9.97 to 33.10. According to the industry distribution chart, Edwards Lifesciences ranks #139 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 17.1%.
Is Edwards Lifesciences' OCF Margin % too high?
Edwards Lifesciences' current OCF Margin % of 2.66% is 90% below median its 10-year median of 25.59. Over the past 10 years, this metric has ranged from a low of 9.97 to a high of 33.10. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Edwards Lifesciences' value of 2.66% is 54.6% below this industry median. Based on the distribution chart, Edwards Lifesciences ranks #139 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Edwards Lifesciences has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' OCF Margin % compare to DXCM and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Edwards Lifesciences ranks #139 out of 815 companies for OCF Margin %. This places Edwards Lifesciences in the top 17% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Edwards Lifesciences' value of 2.66% is 54.6% below this benchmark. Historically, Edwards Lifesciences' own OCF Margin % has ranged from 9.97 to 33.10 over the past decade. While the company's 10-year median is 25.59 vs. the industry median of 5.86, Edwards Lifesciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Edwards Lifesciences's current OCF Margin % of 2.66% is 54.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Edwards Lifesciences and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edwards Lifesciences's current OCF Margin % is 2.66%, which is 90% below median its own 10-year median of 25.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Edwards Lifesciences (EW) is currently considered Fairly Valued. The stock's GF Value™ is $93.14, compared to a current price of $89.66 — trading 3.7% below its estimated fair value. The current OCF Margin % is 2.66%, which is 90% below median its 10-year median of 25.59 and 54.6% below the Medical Devices & Instruments industry median of 5.86. Edwards Lifesciences' overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Edwards Lifesciences (EW), the current OCF Margin % is 2.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Edwards Lifesciences (EW) Overvalued in 2026?
Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued.
The current stock price of $89.66 is trading 3.7% below its estimated GF Value™ of $93.14.
GuruFocus considers Edwards Lifesciences to be Fairly Valued.
Key valuation signals for EW:
OCF Margin %: 2.66% (90% below median its 10-year median of 25.59)
GF Value™: $93.14 vs. price of $89.66 (3.7% below fair value)
Industry Position: 54.6% below the Medical Devices & Instruments median (#139 of 815)
No single metric tells the full story. See the EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
97GF Score
Get the complete analysis for EW
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EW has been successfully added to your 
